Lund, Sweden, December 13, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that senior company representatives will participate in the following industry conferences during January 2023:
- 41st Annual J.P. Morgan Healthcare Conference, January 9 – 12, San Francisco, United States
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, and David Harrison, Head of Business Development at Alligator Bioscience, will be present in San Francisco during the J.P. Morgan 41st Annual Healthcare Conference to meet with investors and potential strategic partners.
- Redeye Fight Cancer Day 2023, January 19, Stockholm
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
- Aktiespararna "Aktiedagen i Lund", January 31, Lund
Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.
The information was submitted for publication, through the agency of the contact persons set out below, at 8:00 a.m. CET on December 13, 2022.